Heart failure (HF) and liver disease often co-exist. This is because systemic disorders and
diseases affect both organs (alcohol abuse, drugs, inflammation, autoimmunity, infections) …

Patients with cirrhosis and portal hypertension often develop complications from a variety of
organ systems leading to a multiple organ failure. The combination of liver failure and portal …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end‐stage liver
disease in the absence of prior heart disease. First defined in 2005 during the World …

In clinical practice, combined heart and liver dysfunctions coexist in the setting of the main
heart and liver diseases because of complex cardiohepatic interactions. It is becoming …

Acute-on-chronic liver failure combines an acute deterioration in liver function in an
individual with pre-existing chronic liver disease and hepatic and extrahepatic organ …

Based on reviews of the literature and experts' consensus, the Chinese Society of
Hepatology developed guidelines for the diagnosis and treatment of liver cirrhosis, in order …

The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

Assessment of major adverse cardiovascular events (MACE) after liver transplantation (LT)
has been limited by the lack of a multicenter study with detailed clinical information. An …

Background and Aims Most tumor cells use aerobic glycolysis (the Warburg effect) to
support anabolic growth and promote tumorigenicity and drug resistance. Intriguingly, the …